{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:41:18Z","timestamp":1793911278841,"version":"4.8.0"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["2024NSFSC0580"],"award-info":[{"award-number":["2024NSFSC0580"]}]},{"name":"Sichuan Science and Technology Program","award":["2023NSFSC1840"],"award-info":[{"award-number":["2023NSFSC1840"]}]},{"name":"Sichuan Science and Technology Program","award":["2022YFS0578, 2022YFS0614"],"award-info":[{"award-number":["2022YFS0578, 2022YFS0614"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20398, 82030007"],"award-info":[{"award-number":["U23A20398, 82030007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Central Government Guides Local Science and Technology Development Project","award":["2022ZYD0057"],"award-info":[{"award-number":["2022ZYD0057"]}]},{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2022YFS0630-B1"],"award-info":[{"award-number":["2022YFS0630-B1"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2022YFS0627-A1"],"award-info":[{"award-number":["2022YFS0627-A1"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["2021ZKMS005"],"award-info":[{"award-number":["2021ZKMS005"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06890-9","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T15:30:15Z","timestamp":1758727815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of tetraspanins in organ fibrosis: mechanisms and therapeutic perspectives"],"prefix":"10.1186","volume":"23","author":[{"given":"Shengbiao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"6890_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","volume":"65","author":"R Weiskirchen","year":"2019","unstructured":"Weiskirchen R, Weiskirchen S, Tacke F. Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications. Mol Aspects Med. 2019;65:2\u201315.","journal-title":"Mol Aspects Med"},{"key":"6890_CR2","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.stem.2022.07.006","volume":"29","author":"HE Talbott","year":"2022","unstructured":"Talbott HE, Mascharak S, Griffin M, Wan DC, Longaker MT. Wound healing, fibroblast heterogeneity, and fibrosis. Cell Stem Cell. 2022;29:1161\u201380.","journal-title":"Cell Stem Cell"},{"key":"6890_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587:555\u201366.","journal-title":"Nature"},{"key":"6890_CR4","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1056\/NEJMra1300575","volume":"372","author":"DC Rockey","year":"2015","unstructured":"Rockey DC, Longo DL, Bell PD, Hill JA. Fibrosis \u2014 A common pathway to organ injury and failure. N Engl J Med. 2015;372:1138\u201349.","journal-title":"N Engl J Med"},{"key":"6890_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3892\/mmr.2024.13324","volume":"30","author":"K Chen","year":"2024","unstructured":"Chen K, Li Q, Li Y, Jiang D, Chen L, Jiang J, et al. Tetraspanins in digestive\u2013system cancers: expression, function and therapeutic potential (review). Mol Med Rep. 2024;30:200.","journal-title":"Mol Med Rep"},{"key":"6890_CR6","doi-asserted-by":"publisher","first-page":"108070","DOI":"10.1016\/j.isci.2023.108070","volume":"26","author":"Y Li","year":"2023","unstructured":"Li Y, Fan S, Kong L, Hao Z, Zhou Y, Shangguan J, et al. CD9 exacerbates pathological cardiac hypertrophy through regulating GP130\/STAT3 signaling pathway. iScience. 2023;26:108070.","journal-title":"iScience"},{"key":"6890_CR7","doi-asserted-by":"publisher","first-page":"5108525","DOI":"10.1155\/2017\/5108525","volume":"2017","author":"J Ryu","year":"2017","unstructured":"Ryu J, Lee JW. TM4SF5-Mediated roles in the development of fibrotic phenotypes. Mediat Inflamm. 2017;2017:5108525.","journal-title":"Mediat Inflamm"},{"key":"6890_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/biof.1693","volume":"47","author":"L Zhang","year":"2020","unstructured":"Zhang L, Huang C, Fan S. Mangiferin and organ fibrosis: A mini review. BioFactors. 2020;47:59\u201368.","journal-title":"BioFactors"},{"key":"6890_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1083\/jcb.200906155","volume":"188","author":"A Masszi","year":"2010","unstructured":"Masszi A, Speight P, Charbonney E, Lodyga M, Nakano H, Sz\u00e1szi K, et al. Fate-determining mechanisms in epithelial\u2013myofibroblast transition: major inhibitory role for Smad3. J Cell Biol. 2010;188:383\u201399.","journal-title":"J Cell Biol"},{"key":"6890_CR10","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1111\/jcmm.14258","volume":"23","author":"G Liu","year":"2019","unstructured":"Liu G, Wang Y, Yang L, Zou B, Gao S, Song Z, et al. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2\/3 and beta-catenin pathway in human pulmonary fibrosis. J Cell Mol Med. 2019;23:3583\u201396.","journal-title":"J Cell Mol Med"},{"key":"6890_CR11","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1016\/j.cub.2020.01.007","volume":"30","author":"T Lang","year":"2020","unstructured":"Lang T, Hochheimer N, Tetraspanins. Curr Biol. 2020;30:R204\u20136.","journal-title":"Curr Biol"},{"key":"6890_CR12","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3389\/fimmu.2018.01074","volume":"9","author":"ML Saiz","year":"2018","unstructured":"Saiz ML, Rocha-Perugini V, S\u00e1nchez-Madrid F. Tetraspanins as organizers of antigen-presenting cell function. Front Immunol. 2018;9:1074.","journal-title":"Front Immunol"},{"key":"6890_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/19336918.2015.1005465","volume":"9","author":"X Jiang","year":"2015","unstructured":"Jiang X, Zhang J, Huang Y. Tetraspanins in cell migration. Cell Adh Migr. 2015;9:406\u201315.","journal-title":"Cell Adh Migr"},{"key":"6890_CR14","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.3390\/ijms21207568","volume":"21","author":"J Jankovi\u010dov\u00e1","year":"2020","unstructured":"Jankovi\u010dov\u00e1 J, Se\u010dov\u00e1 P, Michalkov\u00e1 K, Antal\u00edkov\u00e1 J. Tetraspanins, more than markers of extracellular vesicles in reproduction. Int J Mol Sci. 2020;21:7568.","journal-title":"Int J Mol Sci"},{"key":"6890_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00430-020-00673-3","volume":"209","author":"D Kummer","year":"2020","unstructured":"Kummer D, Steinbacher T, Schwietzer MF, Th\u00f6lmann S, Ebnet K. Tetraspanins: integrating cell surface receptors to functional microdomains in homeostasis and disease. Med Microbiol Immunol. 2020;209:397\u2013405.","journal-title":"Med Microbiol Immunol"},{"key":"6890_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1096\/fasebj.11.6.9194523","volume":"11","author":"HT Maecker","year":"1997","unstructured":"Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J. 1997;11:428\u201342.","journal-title":"FASEB J"},{"key":"6890_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/path.5548","volume":"253","author":"J Ryu","year":"2021","unstructured":"Ryu J, Kim E, Kang M-K, Song D-G, Shin E-A, Lee H, et al. Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression. J Pathol. 2021;253:55\u201367.","journal-title":"J Pathol"},{"key":"6890_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/diacare.28.1.164","volume":"28","author":"JL Gross","year":"2005","unstructured":"Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164\u201376.","journal-title":"Diabetes Care"},{"key":"6890_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1164\/rccm.201201-0117OC","volume":"186","author":"K Tsujino","year":"2012","unstructured":"Tsujino K, Takeda Y, Arai T, Shintani Y, Inagaki R, Saiga H, et al. Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity. Am J Respir Crit Care Med. 2012;186:170\u201380.","journal-title":"Am J Respir Crit Care Med"},{"key":"6890_CR20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/HYPERTENSIONAHA.117.09045","volume":"69","author":"A Takawale","year":"2017","unstructured":"Takawale A, Zhang P, Patel VB, Wang X, Oudit G, Kassiri Z. Tissue inhibitor of matrix Metalloproteinase-1 promotes myocardial fibrosis by mediating CD63-Integrin \u03b21 interaction. Hypertension. 2017;69:1092\u2013103.","journal-title":"Hypertension"},{"key":"6890_CR21","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028\u201340.","journal-title":"Nat Med"},{"key":"6890_CR22","doi-asserted-by":"crossref","unstructured":"Iredale JP, Thompson A, Henderson NC. Extracellular matrix degradation in liver fibrosis: biochemistry and regulation. Biochimica et biophysica acta (BBA) Mol Basis Dis. 2013;1832:876\u201383.","DOI":"10.1016\/j.bbadis.2012.11.002"},{"key":"6890_CR23","doi-asserted-by":"crossref","unstructured":"Mazzarino. Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review). Int J Mol Med. 2009;24:143-152.","DOI":"10.3892\/ijmm_00000217"},{"key":"6890_CR24","doi-asserted-by":"publisher","first-page":"001","DOI":"10.1055\/s-0036-1597816","volume":"37","author":"J Iredale","year":"2017","unstructured":"Iredale J, Campana L. Regression of liver fibrosis. Semin Liver Dis. 2017;37:1\u201310.","journal-title":"Semin Liver Dis"},{"key":"6890_CR25","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2023.05.043","volume":"79","author":"X Zhang","year":"2023","unstructured":"Zhang X, Sharma P, Maschmeyer P, Hu Y, Lou M, Kim J, et al. GARP on hepatic stellate cells is essential for the development of liver fibrosis. J Hepatol. 2023;79:1214\u201325.","journal-title":"J Hepatol"},{"key":"6890_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mam.2007.09.002","volume":"29","author":"M Parola","year":"2008","unstructured":"Parola M, Marra F, Pinzani M. Myofibroblast - like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol Aspects Med. 2008;29:58\u201366.","journal-title":"Mol Aspects Med"},{"key":"6890_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181\u201394.","journal-title":"Nat Rev Immunol"},{"key":"6890_CR28","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015;61:1066\u201379.","journal-title":"Hepatology"},{"key":"6890_CR29","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1097\/MS9.0000000000002095","volume":"86","author":"N Najafi","year":"2024","unstructured":"Najafi N, Razavi A, Jafarpour H, Raei M, Azizi Z, Davoodi L, et al. Evaluation of hepatic injury in chronic hepatitis B and C using APRI and FIB-4 indices compared to fibroscan results. Ann Med Surg (Lond). 2024;86:3841\u20136.","journal-title":"Ann Med Surg (Lond)"},{"key":"6890_CR30","doi-asserted-by":"publisher","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","volume":"20","author":"G Sebastiani","year":"2014","unstructured":"Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol. 2014;20:11033\u201353.","journal-title":"World J Gastroenterol"},{"key":"6890_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/biom14040404","volume":"14","author":"NA Osna","year":"2024","unstructured":"Osna NA, Tikhanovich I, Ortega-Ribera M, Mueller S, Zheng C, Mueller J, et al. Alcohol-Associated liver disease outcomes: critical mechanisms of liver injury progression. Biomolecules. 2024;14:404.","journal-title":"Biomolecules"},{"key":"6890_CR32","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/jgh.13065","volume":"30","author":"T Tu","year":"2015","unstructured":"Tu T, Calabro SR, Lee A, Maczurek AE, Budzinska MA, Warner FJ, et al. Hepatocytes in liver injury: victim, bystander, or accomplice in progressive fibrosis? J Gastroenterol Hepatol. 2015;30:1696\u2013704.","journal-title":"J Gastroenterol Hepatol"},{"key":"6890_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bpg.2011.02.001","volume":"25","author":"M Penz-\u00d6sterreicher","year":"2011","unstructured":"Penz-\u00d6sterreicher M, \u00d6sterreicher CH, Trauner M. Fibrosis in autoimmune and cholestatic liver disease. Best Pract Res Clin Gastroenterol. 2011;25:245\u201358.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"6890_CR34","doi-asserted-by":"publisher","first-page":"12572","DOI":"10.3390\/ijms232012572","volume":"23","author":"D Zhang","year":"2022","unstructured":"Zhang D, Zhang Y, Sun B. The molecular mechanisms of liver fibrosis and its potential therapy in application. Int J Mol Sci. 2022;23:12572.","journal-title":"Int J Mol Sci"},{"key":"6890_CR35","doi-asserted-by":"publisher","first-page":"G807","DOI":"10.1152\/ajpgi.00447.2014","volume":"308","author":"MA Karsdal","year":"2015","unstructured":"Karsdal MA, Manon-Jensen T, Genovese F, Kristensen JH, Nielsen MJ, Sand JMB, et al. Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2015;308:G807\u201330.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"6890_CR36","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/labinvest.2009.77","volume":"89","author":"Y Liu","year":"2009","unstructured":"Liu Y, Wen XM, Lui ELH, Friedman SL, Cui W, Ho NPS, et al. Therapeutic targeting of the PDGF and TGF-\u03b2-signaling pathways in hepatic stellate cells by PTK787\/ZK22258. Lab Invest. 2009;89:1152\u201360.","journal-title":"Lab Invest"},{"key":"6890_CR37","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1113\/JP281061","volume":"600","author":"DR Kamm","year":"2022","unstructured":"Kamm DR, McCommis KS. Hepatic stellate cells in physiology and pathology. J Physiol. 2022;600:1825\u201337.","journal-title":"J Physiol"},{"key":"6890_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27\u201342.","journal-title":"Adv Drug Deliv Rev"},{"key":"6890_CR39","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/cells8111419","volume":"8","author":"B Dewidar","year":"2019","unstructured":"Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019;8:1419.","journal-title":"Cells"},{"key":"6890_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/bs.ircmb.2015.06.004","volume":"319","author":"JW Lee","year":"2015","unstructured":"Lee JW. Transmembrane 4 L six family member 5 (TM4SF5)-mediated epithelial-mesenchymal transition in liver diseases. Int Rev Cell Mol Biol. 2015;319:141\u201363.","journal-title":"Int Rev Cell Mol Biol"},{"key":"6890_CR41","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1096\/fj.201600944RR","volume":"31","author":"H Kim","year":"2017","unstructured":"Kim H, Kwon S, Nam SH, Jung JW, Kang M, Ryu J, et al. Dynamic and coordinated single-molecular interactions at TM4SF5\u2010enriched microdomains guide invasive behaviors in 2\u2010 and 3\u2010dimensional environments. FASEB J. 2017;31:1461\u201381.","journal-title":"FASEB J"},{"key":"6890_CR42","doi-asserted-by":"crossref","unstructured":"Kang M, Ryu J, Lee D, Lee M-S, Kim H-J, Nam SH et al. Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities. Ray RB, editor. PLoS ONE. 2014;9:e102817.","DOI":"10.1371\/journal.pone.0102817"},{"key":"6890_CR43","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1742-4658.2011.08452.x","volume":"279","author":"M Kang","year":"2012","unstructured":"Kang M, Jeong S-J, Park SY, Lee HJ, Kim HJ, Park KH, et al. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice. FEBS J. 2012;279:625\u201335.","journal-title":"FEBS J"},{"key":"6890_CR44","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1172\/JCI33768","volume":"118","author":"S-A Lee","year":"2008","unstructured":"Lee S-A, Lee S-Y, Cho I-H, Oh M-A, Kang E-S, Kim Y-B, et al. Tetraspanin TM4SF5 mediates loss of contact Inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. J Clin Invest. 2008;118:1354\u201366.","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"6890_CR45","first-page":"S122","volume":"23","author":"NM Meindl-Beinker","year":"2008","unstructured":"Meindl-Beinker NM, Dooley S. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis. J Gastroenterol Hepatol. 2008;23(Suppl 1):S122\u2013127.","journal-title":"J Gastroenterol Hepatol"},{"key":"6890_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76\u201399.","journal-title":"J Cell Mol Med"},{"key":"6890_CR47","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1042\/BST20110745","volume":"39","author":"RL Bailey","year":"2011","unstructured":"Bailey RL, Herbert JM, Khan K, Heath VL, Bicknell R, Tomlinson MG. The emerging role of tetraspanin microdomains on endothelial cells. Biochem Soc T. 2011;39:1667\u201373.","journal-title":"Biochem Soc T"},{"key":"6890_CR48","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/bjc.2012.11","volume":"106","author":"MJ Kwon","year":"2012","unstructured":"Kwon MJ, Park S, Choi JY, Oh E, Kim YJ, Park Y-H, et al. Clinical significance of CD151 overexpression in subtypes of invasive breast cancer. Br J Cancer. 2012;106:923\u201330.","journal-title":"Br J Cancer"},{"key":"6890_CR49","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0168-8278(02)00175-7","volume":"37","author":"A Mazzocca","year":"2002","unstructured":"Mazzocca A, Carloni V, Sciammetta S, Cordella C, Pantaleo P, Caldini A, et al. Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration. J Hepatol. 2002;37:322\u201330.","journal-title":"J Hepatol"},{"key":"6890_CR50","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/hep.23137","volume":"50","author":"T-M Hung","year":"2009","unstructured":"Hung T-M, Chang SC, Yu W-H, Wang Y-W, Huang C, Lu S-C, et al. A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis. Hepatology. 2009;50:1184\u201393.","journal-title":"Hepatology"},{"key":"6890_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","volume":"16","author":"JM Banales","year":"2019","unstructured":"Banales JM, Huebert RC, Karlsen T, Strazzabosco M, LaRusso NF, Gores GJ. Cholangiocyte pathobiology. Nat Rev Gastroenterol Hepatol. 2019;16:269\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6890_CR52","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/jhep.2003.50376","volume":"38","author":"NA Shackel","year":"2003","unstructured":"Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Novel differential gene expression in human cirrhosis detected by suppression subtractive hybridization. Hepatology. 2003;38:577\u201388.","journal-title":"Hepatology"},{"key":"6890_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/1096-9071(200101)63:1<22::AID-JMV1003>3.0.CO;2-1","volume":"63","author":"J Itakura","year":"2001","unstructured":"Itakura J, Nagayama K, Enomoto N, Sakamoto N, Tazawa J, Izumi N, et al. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection. J Med Virol. 2001;63:22\u20138.","journal-title":"J Med Virol"},{"key":"6890_CR54","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science. 1998;282:938\u201341.","journal-title":"Science"},{"key":"6890_CR55","doi-asserted-by":"publisher","first-page":"1131588","DOI":"10.3389\/fimmu.2023.1131588","volume":"14","author":"N Zhang","year":"2023","unstructured":"Zhang N, Yao H, Zhang Z, Li Z, Chen X, Zhao Y, et al. Ongoing involvers and promising therapeutic targets of hepatic fibrosis: the hepatic immune microenvironment. Front Immunol. 2023;14:1131588.","journal-title":"Front Immunol"},{"key":"6890_CR56","doi-asserted-by":"publisher","first-page":"110018","DOI":"10.1016\/j.celrep.2021.110018","volume":"37","author":"E Kim","year":"2021","unstructured":"Kim E, Um H, Park J, Jung JW, Kim JE, Lee H, et al. TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment. Cell Rep. 2021;37:110018.","journal-title":"Cell Rep"},{"key":"6890_CR57","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.cmet.2019.03.005","volume":"29","author":"JW Jung","year":"2019","unstructured":"Jung JW, Macalino SJY, Cui M, Kim JE, Kim H-J, Song D-G, et al. Transmembrane 4 L six family member 5 senses arginine for mTORC1 signaling. Cell Metabol. 2019;29:1306\u2013e13197.","journal-title":"Cell Metabol"},{"key":"6890_CR58","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/1535370216675065","volume":"242","author":"R Agarwal","year":"2016","unstructured":"Agarwal R, Agarwal P. Targeting extracellular matrix remodeling in disease: could Resveratrol be a potential candidate? Experimental Biology Med. 2016;242:374\u201383.","journal-title":"Experimental Biology Med"},{"key":"6890_CR59","doi-asserted-by":"publisher","first-page":"101451","DOI":"10.1016\/j.molmet.2022.101451","volume":"58","author":"H Lee","year":"2022","unstructured":"Lee H, Kim E, Shin E-A, Shon JC, Sun H, Kim JE, et al. Crosstalk between TM4SF5 and GLUT8 regulates Fructose metabolism in hepatic steatosis. Mol Metab. 2022;58:101451.","journal-title":"Mol Metab"},{"key":"6890_CR60","doi-asserted-by":"publisher","first-page":"G138","DOI":"10.1152\/ajpgi.00411.2016","volume":"313","author":"JCR Wadkin","year":"2017","unstructured":"Wadkin JCR, Patten DA, Kamarajah SK, Shepherd EL, Novitskaya V, Berditchevski F, et al. CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma. Am J Physiol Gastrointest Liver Physiol. 2017;313:G138\u201349.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"6890_CR61","doi-asserted-by":"publisher","first-page":"983","DOI":"10.4049\/jimmunol.169.2.983","volume":"169","author":"PF Lalor","year":"2002","unstructured":"Lalor PF, Edwards S, McNab G, Salmi M, Jalkanen S, Adams DH. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol. 2002;169:983\u201392.","journal-title":"J Immunol"},{"key":"6890_CR62","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1083\/jcb.200809173","volume":"183","author":"K Ley","year":"2008","unstructured":"Ley K, Zhang H. Dances with leukocytes: how tetraspanin-enriched microdomains assemble to form endothelial adhesive platforms. J Cell Biol. 2008;183:375\u20136.","journal-title":"J Cell Biol"},{"key":"6890_CR63","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","volume":"61","author":"RH Westbrook","year":"2014","unstructured":"Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61:S58\u201368.","journal-title":"J Hepatol"},{"key":"6890_CR64","doi-asserted-by":"publisher","first-page":"11329","DOI":"10.1074\/jbc.M410161200","volume":"280","author":"A Mazzocca","year":"2005","unstructured":"Mazzocca A, Sciammetta SC, Carloni V, Cosmi L, Annunziato F, Harada T, et al. Binding of hepatitis C virus envelope protein E2 to CD81 Up-regulates matrix Metalloproteinase-2 in human hepatic stellate cells. J Biol Chem. 2005;280:11329\u201339.","journal-title":"J Biol Chem"},{"key":"6890_CR65","doi-asserted-by":"publisher","first-page":"19665","DOI":"10.1074\/jbc.M602116200","volume":"281","author":"M Sala-Vald\u00e9s","year":"2006","unstructured":"Sala-Vald\u00e9s M, Ursa \u00c1, Charrin S, Rubinstein E, Hemler ME, S\u00e1nchez-Madrid F, et al. EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with Ezrin-Radixin-Moesin proteins. J Biol Chem. 2006;281:19665\u201375.","journal-title":"J Biol Chem"},{"key":"6890_CR66","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/PL00000933","volume":"58","author":"C Boucheix","year":"2001","unstructured":"Boucheix C, Rubinstein E, Tetraspanins. Cell Mol Life Sci. 2001;58:1189\u2013205.","journal-title":"Cell Mol Life Sci"},{"key":"6890_CR67","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-021-03913-5","volume":"598","author":"A Kumar","year":"2021","unstructured":"Kumar A, Hossain RA, Yost SA, Bu W, Wang Y, Dearborn AD, et al. Structural insights into hepatitis C virus receptor binding and entry. Nature. 2021;598:521\u20135.","journal-title":"Nature"},{"key":"6890_CR68","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature05654","volume":"446","author":"MJ Evans","year":"2007","unstructured":"Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, W\u00f6lk B, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature. 2007;446:801\u20135.","journal-title":"Nature"},{"key":"6890_CR69","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/hep.23445","volume":"51","author":"SE Krieger","year":"2010","unstructured":"Krieger SE, Zeisel MB, Davis C, Thumann C, Harris HJ, Schnober EK, et al. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations. Hepatology. 2010;51:1144\u201357.","journal-title":"Hepatology"},{"key":"6890_CR70","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1128\/JVI.02286-07","volume":"82","author":"HJ Harris","year":"2008","unstructured":"Harris HJ, Farquhar MJ, Mee CJ, Davis C, Reynolds GM, Jennings A, et al. CD81 and Claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol. 2008;82:5007\u201320.","journal-title":"J Virol"},{"key":"6890_CR71","doi-asserted-by":"publisher","first-page":"21092","DOI":"10.1074\/jbc.M110.104836","volume":"285","author":"HJ Harris","year":"2010","unstructured":"Harris HJ, Davis C, Mullins JGL, Hu K, Goodall M, Farquhar MJ, et al. Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem. 2010;285:21092\u2013102.","journal-title":"J Biol Chem"},{"key":"6890_CR72","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm.2341","volume":"17","author":"J Lupberger","year":"2011","unstructured":"Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med. 2011;17:589\u201395.","journal-title":"Nat Med"},{"key":"6890_CR73","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.chom.2013.02.006","volume":"13","author":"L Zona","year":"2013","unstructured":"Zona L, Lupberger J, Sidahmed-Adrar N, Thumann C, Harris HJ, Barnes A, et al. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Cell Host Microbe. 2013;13:302\u201313.","journal-title":"Cell Host Microbe"},{"key":"6890_CR74","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.1074\/jbc.M114.598011","volume":"290","author":"M Ramezani-Moghadam","year":"2015","unstructured":"Ramezani-Moghadam M, Wang J, Ho V, Iseli TJ, Alzahrani B, Xu A, et al. Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion. J Biol Chem. 2015;290:5533\u201342.","journal-title":"J Biol Chem"},{"key":"6890_CR75","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1074\/jbc.M212927200","volume":"278","author":"S Reif","year":"2003","unstructured":"Reif S, Lang A, Lindquist JN, Yata Y, Gabele E, Scanga A, et al. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem. 2003;278:8083\u201390.","journal-title":"J Biol Chem"},{"key":"6890_CR76","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3390\/ijms23052617","volume":"23","author":"K Maruyama","year":"2022","unstructured":"Maruyama K, Imanaka-Yoshida K. The pathogenesis of cardiac fibrosis: A review of recent progress. Int J Mol Sci. 2022;23:2617.","journal-title":"Int J Mol Sci"},{"key":"6890_CR77","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12964-024-01842-0","volume":"22","author":"T Zhang","year":"2024","unstructured":"Zhang T, Jiang D, Zhang X, Chen L, Jiang J, Zhang C, et al. The role of nonmyocardial cells in the development of and the protective effects of FGF21: A current diabetic cardiomyopathyunderstanding. Cell Commun Signal. 2024;22:446.","journal-title":"Cell Commun Signal"},{"key":"6890_CR78","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/biof.1693","volume":"47","author":"L Zhang","year":"2021","unstructured":"Zhang L, Huang C, Fan S. Mangiferin and organ fibrosis: A mini review. BioFactors. 2021;47:59\u201368.","journal-title":"BioFactors"},{"key":"6890_CR79","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/ijms22010356","volume":"22","author":"M Rodriguez-Gonzalez","year":"2020","unstructured":"Rodriguez-Gonzalez M, Lubian-Gutierrez M, Cascales-Poyatos HM, Perez-Reviriego AA, Castellano-Martinez A. Role of the Renin-Angiotensin-Aldosterone system in Dystrophin-Deficient cardiomyopathy. Int J Mol Sci. 2020;22:356.","journal-title":"Int J Mol Sci"},{"key":"6890_CR80","doi-asserted-by":"publisher","first-page":"112132","DOI":"10.1016\/j.biopha.2021.112132","volume":"143","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Abak A, Talebi SF, Shoorei H, Branicki W, Taheri M, et al. Role of MiRNA and LncRNAs in organ fibrosis and aging. Biomed Pharmacother. 2021;143:112132.","journal-title":"Biomed Pharmacother"},{"key":"6890_CR81","doi-asserted-by":"publisher","first-page":"630471","DOI":"10.3389\/fcvm.2021.630471","volume":"8","author":"G Sun","year":"2021","unstructured":"Sun G, Chen J, Ding Y, Wren JD, Xu F, Lu L, et al. A bioinformatics perspective on the links between Tetraspanin-Enriched microdomains and cardiovascular pathophysiology. Front Cardiovasc Med. 2021;8:630471.","journal-title":"Front Cardiovasc Med"},{"key":"6890_CR82","doi-asserted-by":"publisher","unstructured":"Termini CM, Gillette JM. Tetraspanins Function as Regulators of Cellular Signaling. Front Cell Dev Biol [Internet]. 2017 [cited 2025 Jan 14];5. Available from: https:\/\/www.frontiersin.org\/journals\/cell-and-developmental-biology\/articles\/https:\/\/doi.org\/10.3389\/fcell.2017.00034\/full","DOI":"10.3389\/fcell.2017.00034\/full"},{"key":"6890_CR83","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1128\/MCB.01163-08","volume":"29","author":"J Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der J, L\u00fcllmann-Rauch R, Himmerkus N, Pleines I, Nieswandt B, Orinska Z, et al. Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal function. Mol Cell Biol. 2009;29:1083\u201394.","journal-title":"Mol Cell Biol"},{"key":"6890_CR84","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.yexcr.2008.09.020","volume":"315","author":"MS Pols","year":"2009","unstructured":"Pols MS, Klumperman J. Trafficking and function of the tetraspanin CD63. Exp Cell Res. 2009;315:1584\u201392.","journal-title":"Exp Cell Res"},{"key":"6890_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/thno.96990","volume":"15","author":"AA Euan Mart\u00ednez","year":"2025","unstructured":"Euan Mart\u00ednez AA, Bergmann AK, Tellkamp F, Schott-Verdugo S, Bouvain P, Steinhausen J, et al. CD63 as novel target for nanoemulsion-based 19F MRI imaging and drug delivery to activated cardiac fibroblasts. Theranostics. 2025;15:1\u201318.","journal-title":"Theranostics"},{"key":"6890_CR86","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/cvr\/cvp080","volume":"83","author":"F Zhang","year":"2009","unstructured":"Zhang F, Kotha J, Jennings LK, Zhang XA. Tetraspanins and vascular functions. Cardiovascular Res. 2009;83:7\u201315.","journal-title":"Cardiovascular Res"},{"key":"6890_CR87","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nrd2659","volume":"7","author":"ME Hemler","year":"2008","unstructured":"Hemler ME. Targeting of tetraspanin proteins \u2014 potential benefits and strategies. Nat Rev Drug Discov. 2008;7:747\u201358.","journal-title":"Nat Rev Drug Discov"},{"key":"6890_CR88","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1042\/BST0390563","volume":"39","author":"D Powner","year":"2011","unstructured":"Powner D, Kopp PM, Monkley SJ, Critchley DR, Berditchevski F. Tetraspanin CD9 in cell migration. Biochem Soc Trans. 2011;39:563\u20137.","journal-title":"Biochem Soc Trans"},{"key":"6890_CR89","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrc2543","volume":"9","author":"M Z\u00f6ller","year":"2009","unstructured":"Z\u00f6ller M, Tetraspanins. Push and pull in suppressing and promoting metastasis. Nat Rev Cancer. 2009;9:40\u201355.","journal-title":"Nat Rev Cancer"},{"key":"6890_CR90","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1042\/BST0390512","volume":"39","author":"AB van Spriel","year":"2011","unstructured":"van Spriel AB. Tetraspanins in the humoral immune response. Biochem Soc Trans. 2011;39:512\u20137.","journal-title":"Biochem Soc Trans"},{"key":"6890_CR91","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1038\/s41418-020-0537-9","volume":"27","author":"JH Cho","year":"2020","unstructured":"Cho JH, Kim E-C, Son Y, Lee D-W, Park YS, Choi JH, et al. CD9 induces cellular senescence and aggravates atherosclerotic plaque formation. Cell Death Differ. 2020;27:2681\u201396.","journal-title":"Cell Death Differ"},{"key":"6890_CR92","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1172\/JCI13939","volume":"108","author":"H Yasukawa","year":"2001","unstructured":"Yasukawa H, Hoshijima M, Gu Y, Nakamura T, Pradervand S, Hanada T, et al. Suppressor of cytokine signaling-3 is a Biomechanical stress\u2013inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Invest. 2001;108:1459\u201367.","journal-title":"J Clin Invest"},{"key":"6890_CR93","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0008-6363(03)00346-8","volume":"59","author":"C Ancey","year":"2003","unstructured":"Ancey C. Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation. Cardiovascular Res. 2003;59:78\u201385.","journal-title":"Cardiovascular Res"},{"key":"6890_CR94","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00395-007-0658-z","volume":"102","author":"P Fischer","year":"2007","unstructured":"Fischer P, Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res Cardiol. 2007;102:279\u201397.","journal-title":"Basic Res Cardiol"},{"key":"6890_CR95","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s12272-016-0809-6","volume":"39","author":"H Kurose","year":"2016","unstructured":"Kurose H, Mangmool S. Myofibroblasts and inflammatory cells as players of cardiac fibrosis. Arch Pharm Res. 2016;39:1100\u201313.","journal-title":"Arch Pharm Res"},{"key":"6890_CR96","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1513\/AnnalsATS.202305-402OC","volume":"21","author":"SA Gandhi","year":"2024","unstructured":"Gandhi SA, Min B, Fazio JC, Johannson KA, Steinmaus C, Reynolds CJ, et al. The impact of occupational exposures on the risk of idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Ann Am Thorac Soc. 2024;21:486\u201398.","journal-title":"Ann Am Thorac Soc"},{"key":"6890_CR97","doi-asserted-by":"publisher","first-page":"e0230746","DOI":"10.1371\/journal.pone.0230746","volume":"15","author":"K Odashima","year":"2020","unstructured":"Odashima K, Kagiyama N, Kanauchi T, Ishiguro T, Takayanagi N. Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis. PLoS ONE. 2020;15:e0230746.","journal-title":"PLoS ONE"},{"key":"6890_CR98","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/ar3097","volume":"12","author":"FV Castelino","year":"2010","unstructured":"Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther. 2010;12:213.","journal-title":"Arthritis Res Ther"},{"key":"6890_CR99","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/jcm7100356","volume":"7","author":"S Skeoch","year":"2018","unstructured":"Skeoch S, Weatherley N, Swift AJ, Oldroyd A, Johns C, Hayton C, et al. Drug-induced interstitial lung disease: A systematic review. J Clin Med. 2018;7:356.","journal-title":"J Clin Med"},{"key":"6890_CR100","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng.2609","volume":"45","author":"TE Fingerlin","year":"2013","unstructured":"Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet. 2013;45:613\u201320.","journal-title":"Nat Genet"},{"issue":"Suppl 2","key":"6890_CR101","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0300-2896(12)70044-3","volume":"48","author":"A Serrano-Mollar","year":"2012","unstructured":"Serrano-Mollar A. [alveolar epithelial cell injury as an etiopathogenic factor in pulmonary fibrosis]. Arch Bronconeumol. 2012;48(Suppl 2):2\u20136.","journal-title":"Arch Bronconeumol"},{"key":"6890_CR102","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/1381612033392341","volume":"9","author":"M Kelly","year":"2003","unstructured":"Kelly M, Kolb M, Bonniaud P, Gauldie J. Re-evaluation of fibrogenic cytokines in lung fibrosis. CPD. 2003;9:39\u201349.","journal-title":"CPD"},{"key":"6890_CR103","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","volume":"15","author":"JC Bonner","year":"2004","unstructured":"Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004;15:255\u201373.","journal-title":"Cytokine Growth Factor Rev"},{"key":"6890_CR104","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12964-024-01925-y","volume":"22","author":"R Niayesh-Mehr","year":"2024","unstructured":"Niayesh-Mehr R, Kalantar M, Bontempi G, Montaldo C, Ebrahimi S, Allameh A, et al. The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19. Cell Commun Signal. 2024;22:542.","journal-title":"Cell Commun Signal"},{"key":"6890_CR105","first-page":"772","volume":"119","author":"M K\u00f6nigshoff","year":"2009","unstructured":"K\u00f6nigshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest. 2009;119:772\u201387.","journal-title":"J Clin Invest"},{"key":"6890_CR106","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/ars.2007.1908","volume":"10","author":"F Gao","year":"2008","unstructured":"Gao F, Kinnula VL, Myll\u00e4rniemi M, Oury TD. Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal. 2008;10:343\u201354.","journal-title":"Antioxid Redox Signal"},{"key":"6890_CR107","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/j.2040-4603.2020.tb00120.x","volume":"10","author":"E Otoupalova","year":"2020","unstructured":"Otoupalova E, Smith S, Cheng G, Thannickal VJ. Oxidative stress in pulmonary fibrosis. Compr Physiol. 2020;10:509\u201347.","journal-title":"Compr Physiol"},{"key":"6890_CR108","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389:1941\u201352.","journal-title":"Lancet"},{"key":"6890_CR109","doi-asserted-by":"publisher","first-page":"L715","DOI":"10.1152\/ajplung.00361.2009","volume":"298","author":"LM Crosby","year":"2010","unstructured":"Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol. 2010;298:L715\u2013731.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"6890_CR110","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1083\/jcb.200301075","volume":"163","author":"M Shigeta","year":"2003","unstructured":"Shigeta M, Sanzen N, Ozawa M, Gu J, Hasegawa H, Sekiguchi K. CD151 regulates epithelial cell\u2013cell adhesion through PKC- and Cdc42-dependent actin cytoskeletal reorganization. J Cell Biol. 2003;163:165\u201376.","journal-title":"J Cell Biol"},{"key":"6890_CR111","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1242\/jcs.01403","volume":"117","author":"H Moribe","year":"2004","unstructured":"Moribe H, Yochem J, Yamada H, Tabuse Y, Fujimoto T, Mekada E. Tetraspanin protein (TSP-15) is required for epidermal integrity incaenorhabditis elegans. J Cell Sci. 2004;117:5209\u201320.","journal-title":"J Cell Sci"},{"key":"6890_CR112","doi-asserted-by":"publisher","first-page":"585998","DOI":"10.3389\/fgene.2020.585998","volume":"11","author":"LP Tripathi","year":"2020","unstructured":"Tripathi LP, Itoh MN, Takeda Y, Tsujino K, Kondo Y, Kumanogoh A, et al. Integrative analysis reveals common and unique roles of tetraspanins in fibrosis and emphysema. Front Genet. 2020;11:585998.","journal-title":"Front Genet"},{"key":"6890_CR113","doi-asserted-by":"publisher","first-page":"26089","DOI":"10.1074\/jbc.M801902200","volume":"283","author":"Y Takeda","year":"2008","unstructured":"Takeda Y, He P, Tachibana I, Zhou B, Miyado K, Kaneko H, et al. Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice. J Biol Chem. 2008;283:26089\u201397.","journal-title":"J Biol Chem"},{"key":"6890_CR114","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.4049\/jimmunol.0802797","volume":"182","author":"M Suzuki","year":"2009","unstructured":"Suzuki M, Tachibana I, Takeda Y, He P, Minami S, Iwasaki T, et al. Tetraspanin CD9 negatively regulates lipopolysaccharide-induced macrophage activation and lung inflammation. J Immunol. 2009;182:6485\u201393.","journal-title":"J Immunol"},{"key":"6890_CR115","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00011-018-1189-9","volume":"67","author":"L Yang","year":"2018","unstructured":"Yang L, Wang Y, Pan Z, Gao S, Zou B, Lin Z, et al. Tetraspanin 1 inhibits TNF\u03b1-induced apoptosis via NF-\u03baB signaling pathway in alveolar epithelial cells. Inflamm Res. 2018;67:951\u201364.","journal-title":"Inflamm Res"},{"key":"6890_CR116","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112:1776\u201384.","journal-title":"J Clin Invest"},{"key":"6890_CR117","doi-asserted-by":"publisher","first-page":"L525","DOI":"10.1152\/ajplung.00163.2007","volume":"293","author":"BC Willis","year":"2007","unstructured":"Willis BC, Borok Z. TGF-\u03b2-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiology-Lung Cell Mol Physiol. 2007;293:L525\u201334.","journal-title":"Am J Physiology-Lung Cell Mol Physiol"},{"key":"6890_CR118","doi-asserted-by":"crossref","unstructured":"Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z. TGF-\u03b21 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res. 2005;6:56.","DOI":"10.1186\/1465-9921-6-56"},{"key":"6890_CR119","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41419-019-1878-5","volume":"10","author":"JE Kim","year":"2019","unstructured":"Kim JE, Kim H-J, Jung JW, Song D-G, Park D, Lee H, et al. TM4SF5-mediated CD44v8-10 splicing variant promotes survival of type II alveolar epithelial cells during idiopathic pulmonary fibrosis. Cell Death Dis. 2019;10:645.","journal-title":"Cell Death Dis"},{"key":"6890_CR120","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5858\/2009-0144-OA.1","volume":"134","author":"S Fujishima","year":"2010","unstructured":"Fujishima S, Shiomi T, Yamashita S, Yogo Y, Nakano Y, Inoue T, et al. Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis. Arch Pathol Lab Med. 2010;134:1136\u201342.","journal-title":"Arch Pathol Lab Med"},{"key":"6890_CR121","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/labinvest.3700351","volume":"85","author":"T Shiomi","year":"2005","unstructured":"Shiomi T, Inoki I, Kataoka F, Ohtsuka T, Hashimoto G, Nemori R, et al. Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151. Lab Invest. 2005;85:1489\u2013506.","journal-title":"Lab Invest"},{"key":"6890_CR122","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.matbio.2022.06.009","volume":"111","author":"P Duch","year":"2022","unstructured":"Duch P, D\u00edaz-Valdivia N, Ikemori R, Gabasa M, Radisky ES, Arshakyan M, et al. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma. Matrix Biol. 2022;111:207\u201325.","journal-title":"Matrix Biol"},{"key":"6890_CR123","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/17435390.2016.1262919","volume":"11","author":"J Dong","year":"2017","unstructured":"Dong J, Ma Q. TIMP1 promotes multi-walled carbon nanotube-induced lung fibrosis by stimulating fibroblast activation and proliferation. Nanotoxicology. 2017;11:41\u201351.","journal-title":"Nanotoxicology"},{"key":"6890_CR124","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260\u201372.","journal-title":"Lancet"},{"key":"6890_CR125","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mcna.2023.03.004","volume":"107","author":"S Gupta","year":"2023","unstructured":"Gupta S, Dominguez M, Golestaneh L. Diabetic kidney disease: an update. Med Clin North Am. 2023;107:689\u2013705.","journal-title":"Med Clin North Am"},{"key":"6890_CR126","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137\u201388.","journal-title":"Physiol Rev"},{"key":"6890_CR127","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102:248\u201360.","journal-title":"Kidney Int"},{"key":"6890_CR128","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/jhh.2013.55","volume":"28","author":"S Mennuni","year":"2014","unstructured":"Mennuni S, Rubattu S, Pierelli G, Tocci G, Fofi C, Volpe M. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage. J Hum Hypertens. 2014;28:74\u20139.","journal-title":"J Hum Hypertens"},{"key":"6890_CR129","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","volume":"361","author":"A Rajasekaran","year":"2021","unstructured":"Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy: an interesting autoimmune kidney disease. Am J Med Sci. 2021;361:176\u201394.","journal-title":"Am J Med Sci"},{"key":"6890_CR130","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport\u2019s syndrome, goodpasture\u2019s syndrome, and type IV collagen. N Engl J Med. 2003;348:2543\u201356.","journal-title":"N Engl J Med"},{"key":"6890_CR131","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/ndt\/gfz131","volume":"34","author":"R Torra","year":"2019","unstructured":"Torra R, Furlano M. New therapeutic options for Alport syndrome. Nephrol Dial Transpl. 2019;34:1272\u20139.","journal-title":"Nephrol Dial Transpl"},{"key":"6890_CR132","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","volume":"7","author":"Y Liu","year":"2011","unstructured":"Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 2011;7:684\u201396.","journal-title":"Nat Rev Nephrol"},{"key":"6890_CR133","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","volume":"101","author":"L Chen","year":"2018","unstructured":"Chen L, Yang T, Lu D-W, Zhao H, Feng Y-L, Chen H, et al. Central role of dysregulation of TGF-\u03b2\/smad in CKD progression and potential targets of its treatment. Biomed Pharmacother. 2018;101:670\u201381.","journal-title":"Biomed Pharmacother"},{"key":"6890_CR134","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1681\/ASN.2008060566","volume":"20","author":"W He","year":"2009","unstructured":"He W, Dai C, Li Y, Zeng G, Monga SP, Liu Y. Wnt\/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 2009;20:765\u201376.","journal-title":"J Am Soc Nephrol"},{"key":"6890_CR135","doi-asserted-by":"crossref","unstructured":"Zhuang L, Ge X, Hu X, Yang Q, Pei X, Jin G. miR-543 regulates high glucose-induced fibrosis and autophagy in diabetic nephropathy by targeting TSPAN8. BMC Nephrol. 2022;23:89.","DOI":"10.1186\/s12882-022-02716-8"},{"key":"6890_CR136","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.2353\/ajpath.2010.090770","volume":"176","author":"AL Rops","year":"2010","unstructured":"Rops AL, Figdor CG, van der Schaaf A, Tamboer WP, Bakker MA, Berden JH, et al. The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology. Am J Pathol. 2010;176:2188\u201397.","journal-title":"Am J Pathol"},{"key":"6890_CR137","doi-asserted-by":"publisher","first-page":"e1000338","DOI":"10.1371\/journal.ppat.1000338","volume":"5","author":"AB van Spriel","year":"2009","unstructured":"van Spriel AB, Sofi M, Gartlan KH, van der Schaaf A, Verschueren I, Torensma R, et al. The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity. PLoS Pathog. 2009;5:e1000338.","journal-title":"PLoS Pathog"},{"key":"6890_CR138","doi-asserted-by":"publisher","first-page":"e99083","DOI":"10.1371\/journal.pone.0099083","volume":"9","author":"D Delimont","year":"2014","unstructured":"Delimont D, Dufek BM, Meehan DT, Zallocchi M, Gratton MA, Phillips G, et al. Laminin \u03b12-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis. PLoS ONE. 2014;9:e99083.","journal-title":"PLoS ONE"},{"key":"6890_CR139","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1007\/s00467-022-05447-y","volume":"37","author":"RW Naylor","year":"2022","unstructured":"Naylor RW, Watson E, Williamson S, Preston R, Davenport JB, Thornton N, et al. Basement membrane defects in CD151-associated glomerular disease. Pediatr Nephrol. 2022;37:3105\u201315.","journal-title":"Pediatr Nephrol"},{"key":"6890_CR140","doi-asserted-by":"publisher","first-page":"101530","DOI":"10.1016\/j.jbc.2021.101530","volume":"298","author":"L Moretti","year":"2022","unstructured":"Moretti L, Stalfort J, Barker TH, Abebayehu D. The interplay of fibroblasts, the extracellular matrix, and inflammation in Scar formation. J Biol Chem. 2022;298:101530.","journal-title":"J Biol Chem"},{"key":"6890_CR141","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s10020-024-00925-5","volume":"30","author":"W Huang","year":"2024","unstructured":"Huang W, Zhang Z, Li X, Zheng Q, Wu C, Liu L, et al. CD9 promotes T\u03b2R2-T\u03b2R1 association driving the transition of human dermal fibroblasts to myofibroblast under hypoxia. Mol Med. 2024;30:162.","journal-title":"Mol Med"},{"key":"6890_CR142","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jdermsci.2016.06.013","volume":"84","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Jinnin M, Harada M, Kudo H, Nakayama W, Inoue K, et al. Altered expression of CD63 and exosomes in scleroderma dermal fibroblasts. J Dermatol Sci. 2016;84:30\u20139.","journal-title":"J Dermatol Sci"},{"key":"6890_CR143","doi-asserted-by":"publisher","first-page":"29181","DOI":"10.1074\/jbc.272.46.29181","volume":"272","author":"I Tachibana","year":"1997","unstructured":"Tachibana I, Bodorova J, Berditchevski F, Zutter MM, Hemler ME. NAG-2, a novel Transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. J Biol Chem. 1997;272:29181\u20139.","journal-title":"J Biol Chem"},{"key":"6890_CR144","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/intimm\/dxq016","volume":"22","author":"E Traggiai","year":"2010","unstructured":"Traggiai E, Lunardi C, Bason C, Dolcino M, Tinazzi E, Corrocher R, et al. Generation of anti-NAG-2 mAb from patients\u2019 memory B cells: implications for a novel therapeutic strategy in systemic sclerosis. Int Immunol. 2010;22:367\u201374.","journal-title":"Int Immunol"},{"key":"6890_CR145","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jdcr.2022.03.012","volume":"23","author":"C Dunn","year":"2022","unstructured":"Dunn C, Ambur A, Foss M, Nathoo R. Expanding the spectrum of epidermolysis Bullosa simplex: syndromic epidermolysis Bullosa simplex with nephropathy and epilepsy secondary to CD151 tetraspanin defect\u2014a case report and review of the literature. JAAD Case Rep. 2022;23:136\u201340.","journal-title":"JAAD Case Rep"},{"key":"6890_CR146","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41433-019-0736-0","volume":"34","author":"TB McKay","year":"2020","unstructured":"McKay TB, Hutcheon AEK, Zieske JD. Biology of corneal fibrosis: soluble mediators, integrins, and extracellular vesicles. Eye (Lond). 2020;34:271\u20138.","journal-title":"Eye (Lond)"},{"key":"6890_CR147","doi-asserted-by":"publisher","first-page":"951","DOI":"10.18240\/ijo.2024.05.21","volume":"17","author":"C Caruso","year":"2024","unstructured":"Caruso C, D\u2019Andrea L, Troisi M, Rinaldi M, Piscopo R, Troisi S, et al. Corneal collagen cross-linking in patients with keratoconus from the Dresden protocol to customized solutions: theoretical basis. Int J Ophthalmol. 2024;17:951\u201362.","journal-title":"Int J Ophthalmol"},{"key":"6890_CR148","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1566523221666210423084233","volume":"22","author":"C Amador","year":"2022","unstructured":"Amador C, Shah R, Ghiam S, Kramerov AA, Ljubimov AV. Gene therapy in the anterior eye segment. Curr Gene Ther. 2022;22:104\u201331.","journal-title":"Curr Gene Ther"},{"key":"6890_CR149","doi-asserted-by":"publisher","first-page":"108090","DOI":"10.1016\/j.exer.2020.108090","volume":"197","author":"RC de Oliveira","year":"2020","unstructured":"de Oliveira RC, Wilson SE. Descemet\u2019s membrane development, structure, function and regeneration. Exp Eye Res. 2020;197:108090.","journal-title":"Exp Eye Res"},{"key":"6890_CR150","doi-asserted-by":"publisher","first-page":"108272","DOI":"10.1016\/j.exer.2020.108272","volume":"201","author":"SE Wilson","year":"2020","unstructured":"Wilson SE. Corneal myofibroblasts and fibrosis. Exp Eye Res. 2020;201:108272.","journal-title":"Exp Eye Res"},{"key":"6890_CR151","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.3390\/ijms23084330","volume":"23","author":"P Escandon","year":"2022","unstructured":"Escandon P, Liu A, Nicholas SE, Khan A, Riaz KM, Karamichos D. Unravelling novel roles of salivary exosomes in the regulation of human corneal stromal cell migration and wound healing. Int J Mol Sci. 2022;23:4330.","journal-title":"Int J Mol Sci"},{"key":"6890_CR152","doi-asserted-by":"publisher","first-page":"40548","DOI":"10.1038\/srep40548","volume":"7","author":"K-Y Han","year":"2017","unstructured":"Han K-Y, Tran JA, Chang J-H, Azar DT, Zieske JD. Potential role of corneal epithelial cell-derived exosomes in corneal wound healing and neovascularization. Sci Rep-uk. 2017;7:40548.","journal-title":"Sci Rep-uk"},{"key":"6890_CR153","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.3390\/ijms23115921","volume":"23","author":"V Yeung","year":"2022","unstructured":"Yeung V, Boychev N, Farhat W, Ntentakis DP, Hutcheon AEK, Ross AE, et al. Extracellular vesicles in corneal fibrosis\/scarring. Int J Mol Sci. 2022;23:5921.","journal-title":"Int J Mol Sci"},{"key":"6890_CR154","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/s41375-019-0475-z","volume":"33","author":"S Stilgenbauer","year":"2019","unstructured":"Stilgenbauer S, Aurran Schleinitz T, Eichhorst B, Lang F, Offner F, Rossi J-F, et al. Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed\/refractory chronic lymphocytic leukemia. Leukemia. 2019;33:2531\u20135.","journal-title":"Leukemia"},{"key":"6890_CR155","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s10637-020-01056-4","volume":"39","author":"AV Danilov","year":"2021","unstructured":"Danilov AV, Spurgeon SE, Siddiqi T, Quinson A-M, Maier D, Smith D, et al. A phase ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed\/refractory chronic lymphocytic leukemia. Invest New Drugs. 2021;39:1099\u2013105.","journal-title":"Invest New Drugs"},{"key":"6890_CR156","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejogrb.2025.01.011","volume":"306","author":"K Nakamura","year":"2025","unstructured":"Nakamura K, Ida N, Hirasawa A, Okamoto K, Vu TH, Hai Ly DT, et al. CD63 as a potential biomarker for patients with ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 2025;306:87\u201393.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"6890_CR157","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5114\/pjp.2019.90394","volume":"70","author":"H Koh","year":"2019","unstructured":"Koh H, An H, Jung J, Song D. The prognostic significance of CD63 expressionin patients with non-small cell lung cancer. Pol J Pathol. 2019;70:183\u20138.","journal-title":"Pol J Pathol"},{"key":"6890_CR158","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12876-022-02228-7","volume":"22","author":"H Odaka","year":"2022","unstructured":"Odaka H, Hiemori K, Shimoda A, Akiyoshi K, Tateno H. CD63-positive extracellular vesicles are potential diagnostic biomarkers of pancreatic ductal adenocarcinoma. BMC Gastroenterol. 2022;22:153.","journal-title":"BMC Gastroenterol"},{"key":"6890_CR159","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jhep.2021.09.032","volume":"76","author":"J Qing","year":"2022","unstructured":"Qing J, Ren Y, Zhang Y, Yan M, Zhang H, Wu D, et al. Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis. J Hepatol. 2022;76:394\u2013406.","journal-title":"J Hepatol"},{"key":"6890_CR160","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/liv.12700","volume":"35","author":"MJ Nielsen","year":"2015","unstructured":"Nielsen MJ, Veidal SS, Karsdal MA, \u00d8rsnes-Leeming DJ, Vainer B, Gardner SD, et al. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C. Liver Int. 2015;35:429\u201337.","journal-title":"Liver Int"},{"key":"6890_CR161","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00330-015-3949-z","volume":"26","author":"S Singh","year":"2016","unstructured":"Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, et al. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol. 2016;26:1431\u201340.","journal-title":"Eur Radiol"},{"key":"6890_CR162","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1021\/acsnano.0c02633","volume":"14","author":"J Zhang","year":"2020","unstructured":"Zhang J, Shen H, Xu J, Liu L, Tan J, Li M, et al. Liver-targeted SiRNA lipid nanoparticles treat hepatic cirrhosis by dual antifibrotic and anti-inflammatory activities. ACS Nano. 2020;14:6305\u201322.","journal-title":"ACS Nano"},{"key":"6890_CR163","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","volume":"8","author":"L Richeldi","year":"2020","unstructured":"Richeldi L, Fern\u00e1ndez P\u00e9rez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, et al. Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): A phase 2, randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2020;8:25\u201333.","journal-title":"Lancet Respir Med"},{"key":"6890_CR164","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.aaf2403","volume":"353","author":"PL St\u00e5hl","year":"2016","unstructured":"St\u00e5hl PL, Salm\u00e9n F, Vickovic S, Lundmark A, Navarro JF, Magnusson J, et al. Visualization and analysis of gene expression in tissue sections by Spatial transcriptomics. Science. 2016;353:78\u201382.","journal-title":"Science"},{"key":"6890_CR165","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1188302","volume":"328","author":"D Huh","year":"2010","unstructured":"Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662\u20138.","journal-title":"Science"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06890-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:03:13Z","timestamp":1758733393000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06890-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":165,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6890"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06890-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We give our consent for the manuscript to be published in Cell Communication and Signaling.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1007"}}